| Literature DB >> 26732096 |
Robin J Taylor1,2, Fraz Umar3,4, Erica L S Lin5, Amar Ahmed6, William E Moody7,8, Wojciech Mazur9, Berthold Stegemann10, Jonathan N Townend11,12, Richard P Steeds13,14, Francisco Leyva15,16.
Abstract
BACKGROUND: Left ventricular (LV) mid-wall fibrosis (MWF), which occurs in about a quarter of patients with non-ischemic cardiomyopathy (NICM), is associated with high risk of pump failure. The mid LV wall is the site of circumferential myocardial fibers. We sought to determine the effect of MWF on LV myocardial mechanics.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26732096 PMCID: PMC4700639 DOI: 10.1186/s12968-015-0221-2
Source DB: PubMed Journal: J Cardiovasc Magn Reson ISSN: 1097-6647 Impact factor: 5.364
Fig. 1Rotational mechanics in NICM. Diagrammatic representation of torsional and rotational patterns identified using feature-tracking cardiovascular magnetic resonance. In the bottom tiles, the time in the cardiac cycle, expressed as a percentage of the R-R interval on the ECG, is shown in the x axes. Rotation at the base and apex of the LV as well as net torsion (the instantaneous difference between apical and basal rotation) is shown on the y axis (in degrees) a shows a preserved torsional pattern from a patient with non-ischemic dilated cardiomyopathy without MWF with predominantly anticlockwise rotation at the apex and clockwise rotation at the base. b shows reverse torsion, where the direction of both apical and basal rotation is reversed. c shows rigid body rotation in a patient with NICM and MWF. The apex and base both twist in the same direction so that the heart rotates as one solid body with minimal net torsion
Baseline characteristics
| No MWF | MWF | P | |
|---|---|---|---|
| N | 84 | 32 | |
| Age, yrs | 62.3 ± 13.7 | 63.8 ± 11.9 | 0.29 |
| Male, n (%) | 51 (61) | 27 (84) | 0.02 |
| Height, m | 1.68 ± 0.09 | 1.74 ± 0.09 | 0.02 |
| Weight, Kg | 83.4 ± 18.6 | 83.3 ± 12.6 | 0.97 |
| NYHA class | 0.20 | ||
| I | 4 (5) | 3 (9) | |
| II | 15 (18) | 8 (25) | |
| III | 47 (56) | 11 (34) | |
| IV | 9 (11) | 5 (16) | |
| Unknown | 9 (11) | 5 (16) | |
| Diabetes mellitus, n (%) | 13 (16) | 7 (24) | 0.42 |
| Hypertension, n (%) | 18 (22) | 5 (17) | 0.61 |
| Atrial fibrillation, n (%) | 15 (18) | 8 (24) | 0.44 |
| Medication, n (%) | |||
| Loop diuretics | 62 (81) | 26 (89) | 0.47 |
| ACE-I or ARB | 77 (97) | 27 (90) | 0.31 |
| Beta-blockers | 51 (65) | 20 (66) | 1.00 |
| Aldosterone antagonists | 36 (46) | 10 (35) | 0.29 |
| Systolic blood pressure, mmHg | 124.3 ± 20.5 | 119.6 ± 23.1 | 0.38 |
| Diastolic blood pressure, mmHg | 71.5 ± 11.9 | 71.7 ± 13.8 | 0.96 |
| QRS duration (ms) | 144 (28) | 149 (32) | 0.48 |
ACE-I angiotensin-converting enzyme inhibitors, ARB angiotensin receptor blockers
Mechanical variables in patients with or without MWF
| No MWF | MWF | P | |
|---|---|---|---|
| LV dimensions | |||
| LVEDV, mL | 222 ± 80 | 277 ± 79 | 0.002 |
| LVESV, mL | 166 ± 79 | 214 ± 83 | 0.007 |
| LV mass, g | 137.6 ± 46.6 | 155.5 ± 71.1 | 0.052 |
| Systolic deformation | |||
| LVEF, % | 27.5 ± 10.8 | 24.3 ± 12.9 | 0.20 |
| Ɛcc (%) | −9.4 ± 4.76 | −6.6 (2.57 | 0.004 |
| SSRcc (s−1) | −0.56 ± 0.25 | −0.38 (0.12 | 0.005 |
| Ɛrr (%) | 17.8 ± 11.0 | 14.6 ± 10.1 | 0.18 |
| SSRrr (s−1) | 0.84 ± 0.37 | 0.74 ± 0.40 | 0.31 |
| Ɛll (%) | −9.4 ± 4.35 | −7.6 ± 3.34 | 0.053 |
| SSRll (s−1) | 0.56 ± 0.20 | −0.49 ± 0.18 | 0.13 |
| Diastolic deformation | |||
| DSRcc (s−1) | 0.46 ± 0.19 | 0.34 ± 0.11 | 0.010 |
| DSRrr (s−1) | −0.75 ± 0.35 | −0.55 ± 0.44 | 0.038 |
| DSRll (s−1) | 0.50 ± 0.20 | 0.38 ± 0.14 | 0.006 |
| Systolic torsion | |||
| Basal systolic rotation (°) | |||
| Net Clockwise | 3.40 ± 3.00 | 3.00 ± 2.23 | 0.513 |
| Magnitude | 4.63 ± 2.64 | 3.67 ± 1.97 | 0.082 |
| Basal rotation rate (° s−1) | 31.3 ± 14.5 | 22.1 ± 8.2 | 0.002 |
| Apical systolic rotation (°) | |||
| Net anti-clockwise | −3.50 ± 3.28 | −1.99 ± 1.97 | 0.024 |
| Magnitude | 5.18 ± 3.15 | 3.52 ± 2.45 | 0.013 |
| Apical rotation rate (° s−1) | −38.9 ± 21.8 | −26.1 ± 15.8 | 0.005 |
| Average basal/apical rotation (°) | 9.81 ± 4.48 | 7.20 ± 3.44 | 0.002 |
| LV twist (°) | 6.31 ± 3.30 | 4.65 ± 2.18 | 0.004 |
| LV twist per unit length (°/cm) | 1.34 ± 0.76 | 0.94 ± 0.55 | 0.005 |
| Torsional shear angle | 0.83 ± 0.06 | 0.52 ± 0.07 | 0.008 |
| LV twist rate (° s−1) | 48.4 ± 23.1 | 36.1 ± 17.1 | 0.01 |
| Torsional pattern | <0.001 | ||
| Normal torsion, n (%) | 39 ± 46 | 10 ± 32 | |
| Rigid body rotation, n (%) | 23 ± 28 | 21 ± 64 | |
| Reverse torsion, n (%) | 22 ± 26 | 1 ± 4 | |
| Diastolic torsion | |||
| Basal rotation rate (° s−1) | −34.1 ± 14.8 | −28.0 ± 11.8 | 0.053 |
| Apical rotation rate (° s−1) | 38.3 ± 20.1 | 24.9 ± 13.1 | 0.001 |
| LV untwist rate (° s−1) | 44.5 ± 21.0 | 30.5 ± 14.9 | <0.001 |
Variables are expressed as mean ± SD
MWF mid-wall fibrosis, SSR systolic strain rate, DSR diastolic strain rate, Ɛ strain
Fig. 2Feature-tracking CMR. Short-axis, late gadolinium enhancement views of patients with idiopathic dilated cardiomyopathy, without and with mid-wall fibrosis (MWF, white arrows). The bottom tiles show plots of global circumferential strain (Ɛcc, purple), global radial strain (Ɛrr, red) and global longitudinal strain (Ɛll, green) over a cardiac cycle. Note the marked reduction in Ɛcc in the patient with MWF
Fig. 3Relationship between LVEF and myocardial strain. Scattergrams for each of the Lagrangian strains plotted against LVEF. Cases are classified according to presence (blue circles) or absence (red circles) of mid-wall fibrosis (MWF). The lines correspond to the 95 % confidence intervals for strain. The top scattergram demonstrates that above an LVEF of 25 % (dashed reference line) MWF alters the relationship between Ɛcc and LVEF: patients with MWF have lower Ɛcc than those with similar LVEF but without MWF